Department of Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Ann Oncol. 2013 Dec;24 Suppl 11:xi60-4. doi: 10.1093/annonc/mdt504.
The reports of the Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East, together with the previous 2010 European Society for Medical Oncology (ESMO)/European Association for Palliative Care (EAPC) report from Europe, have provided critical data in demonstrating the deficiencies in many countries throughout the world. Formulary deficiencies and over-regulation are pandemic and must be addressed. This process is challenging and will require concerted and sustained efforts by clinical leaders and advocacy groups partnering with international and regional organizations and, of course, with national governments and their competent authorities. There is a growing international expertise and infrastructure to coordinate advocacy and strategic planning based on the World Health Organization (WHO) Model of Education, Policy Reform and Medication Availability.
全球阿片类药物政策倡议 (GOPI) 项目报告评估了非洲、亚洲、拉丁美洲和加勒比以及中东地区管理癌症疼痛的阿片类药物的可及性和可及性，以及之前 2010 年欧洲肿瘤内科学会 (ESMO)/欧洲姑息治疗协会 (EAPC) 来自欧洲的报告，为展示世界许多国家的缺陷提供了关键数据。处方集缺陷和过度监管是普遍存在的，必须加以解决。这个过程具有挑战性，需要临床领导者和倡导团体与国际和地区组织合作，并与国家政府及其主管部门合作，进行协调一致和持续的努力。基于世界卫生组织 (WHO) 的教育、政策改革和药物供应模式，协调宣传和战略规划的国际专门知识和基础设施正在不断发展。
